| Zacks Company Profile for Surmodics, Inc. (SRDX : NSDQ) |
|
|
| |
| • Company Description |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Number of Employees: 447 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $18.23 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 80,437 shares |
| Shares Outstanding: 14.13 (millions) |
| Market Capitalization: $257.64 (millions) |
| Beta: 1.00 |
| 52 Week High: $39.99 |
| 52 Week Low: $16.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-16.30% |
-19.47% |
| 12 Week |
-6.56% |
-13.26% |
| Year To Date |
-46.57% |
-51.40% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
9924 WEST 74TH STREET
-
EDEN PRAIRIE,MN 55344
USA |
ph: 952-500-7000
fax: 952-500-7001 |
ir@surmodics.com |
http://www.surmodics.com |
|
|
| |
| • General Corporate Information |
Officers
Gary R. Maharaj - President and Chief Executive Officer
Timothy J. Arens - Senior Vice President of Finance and Vice Presiden
Jose H. Bedoya - Director
David R. Dantzker - Director
Ronald B. Kalich - Director
|
|
Peer Information
Surmodics, Inc. (BJCT)
Surmodics, Inc. (CADMQ)
Surmodics, Inc. (APNO)
Surmodics, Inc. (UPDC)
Surmodics, Inc. (IMTIQ)
Surmodics, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 868873100
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/23
Next Expected EPS Date: 07/26/23
|
|
Share - Related Items
Shares Outstanding: 14.13
Most Recent Split Date: 12.00 (2.00:1)
Beta: 1.00
Market Capitalization: $257.64 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.47 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-1.85 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/26/23 |
|
|
|
| |
